Assessing cardiac irisin activities and their associations on coronary and endothelial activities to compare their recoveries from oxidative stress-induced cardiac cell injury by Chunglijagam-tang, a Korean herbal medicine for “Heart Governs Vessels”

  • Ho-Sung Lee
  • Seung Hoon Lee
  • Sunoh Kwon
  • Chae Rim Lee
  • Dal-Seok OhEmail author
Short Communication


Involuntary cardiac pumping supplies oxygen and nutrients into coronary and peripheral arteries, which has been recognized as main dynamics of body. Among the molecules regarding cardiac dynamics, we aimed to investigate whether oxidative stress would induce the production of the exercise hormone and its levels could be regulated by herbal medicine, which represents “Heart Governs Vessels.” We searched MEDLINE for exercise hormone and screened titles and abstracts. The primary human myocardial, coronary arterial and peripheral cell lines were treated with hydrogen peroxide to mimic oxidative stress condition. Activity of irisin, an exercise hormone, was measured by ELISA assay. Expression of NADPH oxidase 2, an irisin’s putative target, was determined by immunoblot assay. Among the cardiovascular effects, we found that left ventricular systolic functions could be affected by several molecules, including irisin. In primary myocardial, coronary arterial and peripheral cell lines, irisin secretion and NADPH oxidase 2 expression was increased by 75 µM hydrogen peroxide. Interestingly, ChungliJagam-tang inhibited NOX2 activities by 31.45%, 42.62%, and 47.22% in an oxidative stress-induced primary myocardial, coronary arterial and peripheral cell lines, respectively. In conclusion, the changes in NOX2 level under an oxidative stress condition which mimicked left ventricular functions are associated with cardiac irisin activities and they were controlled by the herbal prescription on “Heart Governs Vessels”.


Cardiovascular Irisin FNDC5 Heart Governs Vessels NADPH oxidase 2 



The study was funded by Korea Institute of Oriental Medicine (KIOM, Grant # K18891).

Compliance with ethical standards

Ethical statement


Conflict of interest

This manuscript described has not been published before; not under consideration for publication anywhere else; and has been approved by all co-author.


  1. Akki A, Zhang M, Murdoch C, Brewer A, Shah AM (2009) NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47:15–22. CrossRefGoogle Scholar
  2. Anastasilakis AD et al (2017) Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy. Metabolism 73:1–8. CrossRefGoogle Scholar
  3. Aydin S et al (2014) Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides 52:68–73. CrossRefGoogle Scholar
  4. Bostrom P et al (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468. CrossRefGoogle Scholar
  5. Braam B, Joles JA, Danishwar AH, Gaillard CA (2014) Cardiorenal syndrome—current understanding and future perspectives. Nat Rev Nephrol 10:48–55. CrossRefGoogle Scholar
  6. Brailoiu E, Deliu E, Sporici RA, Brailoiu GC (2015) Irisin evokes bradycardia by activating cardiac-projecting neurons of nucleus ambiguus. Physiol Rep. Google Scholar
  7. Efe TH et al (2017) Serum irisin level can predict the severity of coronary artery disease in patients with stable angina. Korean Circ J 47:44–49. CrossRefGoogle Scholar
  8. Fu J, Han Y, Wang J, Jose PA, Zeng C (2016a) Irisin lowered blood pressure by augmenting acetylcholine-mediated vasodilation via AMPK-Akt-eNOS-NO signal pathway in the spontaneously hypertensive rat. J Am Soc Hypertens 10(Suppl 1):e4. CrossRefGoogle Scholar
  9. Fu J et al (2016b) Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK-Akt-eNOS-NO pathway in the spontaneously hypertensive rat. J Am Heart Assoc. Google Scholar
  10. Gray SP, Jandeleit-Dahm KA (2015) The role of NADPH oxidase in vascular disease–hypertension, atherosclerosis and stroke. Curr Pharm Des 21:5933–5944CrossRefGoogle Scholar
  11. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61:1725–1738. CrossRefGoogle Scholar
  12. Huh JY, Mougios V, Skraparlis A, Kabasakalis A, Mantzoros CS (2014) Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism 63:918–921. CrossRefGoogle Scholar
  13. Ishida J, Konishi M, Saitoh M, Anker M, Anker SD, Springer J (2017) Myostatin signaling is up-regulated in female patients with advanced heart failure. Int J Cardiol 238:37–42. CrossRefGoogle Scholar
  14. Jiang R et al (2017) Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort. Am Heart J 190:40–45. CrossRefGoogle Scholar
  15. Kaibe M et al (2005) Serum interleukin-15 concentration in patients with essential hypertension. Am J Hypertens 18:1019–1025. CrossRefGoogle Scholar
  16. Lassegue B, San Martin A, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:1364–1390. CrossRefGoogle Scholar
  17. Li B et al (2015) Activation of NADPH oxidase mediates increased endoplasmic reticulum stress and left ventricular remodeling after myocardial infarction in rabbits. Biochim Biophys Acta 1852:805–815. CrossRefGoogle Scholar
  18. Murdoch CE et al (2014) Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition. J Am Coll Cardiol 63:2734–2741. CrossRefGoogle Scholar
  19. Park Y-S, Yoon G-M, Im E-Y, Shin H-C, Kang S-B (2010) Effects of Chunglijagam-tang Aqueous Extracts on streptozotocin-induced rat diabetes and related complications. J Korean Orient Intern Med 31(3):631–649Google Scholar
  20. Pullaiah CP, Kumar GN, Jyothsna K, Thyagaraju K, Nelson VK, Reddy GD (2017) Rosa damascena Mill. L. attenuates myocardial lysosomal membrane destabilization in isoproterenol induced oxidative stress. Orient Pharm Exp Med 17:373–380CrossRefGoogle Scholar
  21. Shen S et al (2017) Serum irisin predicts mortality risk in acute heart failure patients. Cell Physiol Biochem 42:615–622. CrossRefGoogle Scholar
  22. Sundarrajan L, Yeung C, Hahn L, Weber LP, Unniappan S (2017) Irisin regulates cardiac physiology in zebrafish. PLoS ONE 12:e0181461. CrossRefGoogle Scholar
  23. Tsuchiya Y, Ando D, Goto K, Kiuchi M, Yamakita M, Koyama K (2014) High-intensity exercise causes greater irisin response compared with low-intensity exercise under similar energy consumption. Tohoku J Exp Med 233:135–140CrossRefGoogle Scholar
  24. Violi F et al (2009) Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120:1616–1622. CrossRefGoogle Scholar
  25. Wang H et al (2017) Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury. J Cell Physiol 232:3775–3785. CrossRefGoogle Scholar
  26. Zhang Y et al (2016) Protective effect of irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction. PLoS ONE 11:e0158038. CrossRefGoogle Scholar

Copyright information

© Institute of Korean Medicine, Kyung Hee University 2019

Authors and Affiliations

  1. 1.Clinical Medicine DivisionKorea Institute of Oriental Medicine (KIOM)DaejeonSouth Korea
  2. 2.Herbal Medicine Research DivisionKIOMDaejeonSouth Korea

Personalised recommendations